Register | Forgot password?
Switch to Arabic
Wednesday, February 10 - 2010

Leaders in healthcare exchange views on medical tourism at Healthcare Travel

  • United Arab Emirates: Sunday, November 15 - 2009 at 14:39
  • PRESS RELEASE

Globalisation of healthcare is irretrievably linked to the phenomena known as 'medical tourism' with more and more people seeking medical treatment abroad. The latest World Bank report indicates that medical tourism is already a $65bn business and is set to grow further with the globalisation of the healthcare industry.

Article continues below
 
Key factors driving the globalisation of healthcare is the cost factor with exorbitant healthcare costs in industrialised nations, long waiting lists for surgery and the aging population in countries such as America and Europe.

During the opening session of the Healthcare Travel Congress, an IIR Middle East crafted event being held from 10am to 6pm at the Al Bustan Rotana Hotel Dubai from 15 to 17 November 2009, world-renowned healthcare leaders from across the globe discussed the past, present and future of healthcare supply and demand.

Vishal Bali, CEO of Wockhardt Hospitals Group, India, highlighted the impact that globalisation has had on the healthcare industry and how medical tourism is growing as a result of this trend.

"Globalisation is the optimisation of competencies in various parts of the world to create value for the healthcare consumer and the healthcare provider alike," said Mr Bali. "The healthcare sector is decentralising itself from the individual hubs and moving towards a more global approach to healthcare, working within a framework of transparency and truly creating a choice for the consumer."

"The world can now fully understand the proposition of a merger between two industries - healthcare and tourism - and although the clinical side of healthcare travel is increasingly being elevated and the element or tourism is often secondary, the driver and catalyst for change in this industry has come from accessibility of services, the migration of the healthcare workforce and the need for quality healthcare service providers across the globe," he said.

The Dubai Health Authority (DHA) has recently gone through a reform process where the total healthcare strategic direction has been revised to incorporate the globalisation of healthcare and the potential to benefit from the movement of patients within the region and from abroad. Ms Laila Al Jassmi, CEO of the Clinical Support Services Sector of the DHA, spoke about how globalisation of healthcare has allowed the UAE to look outside its boundaries to learn from medical best-practices adopted abroad.

"This region, namely the GCC, is working towards creating a profitable medical tourism industry but we recognise that we have some way to go before this industry is mature," said Ms Jassmi. "We need to increase the demand and supply of our healthcare sector and this can only be done by restructuring and enhancing our in-house healthcare strategy. In order to boost this country into medical tourism we need to ensure everyone, both UAE nationals and residents, have equal access to healthcare first. The government recognises that our patients still require the expertise from medical professionals abroad which is why we have increased the number of visiting physicians by 10% per year."

Dr Mamdouh Ayad, strategic affairs director for Johnson & Johnson, UAE, discussed his company's role as a worldwide leader in healthcare on a global level as well as some of the regional initiatives Johnson & Johnson have taken towards advancement of the healthcare sector in the UAE.

Dr Mamdouh explained, "Johnson & Johnson Medical Middle East has a continuing commitment to research and development and we are focussing on professional education and developing the skill-gaps of local medical professionals in the region. So far over 20,000 doctors from countries such as the UAE, Saudi Arabia and Lebanon have taken part in an exchange programme where local doctors acquire knowledge and skills from Europe and America and then implement these skills when back in the region. By developing centres-of-excellence, such as Dubai Healthcare City, the infrastructure for healthcare in the UAE can be developed so that we are able to deliver locally the same standard of health as in the west."

With patients becoming more and more educated on issues related to their health, patient safety and medical liability is becoming an important issue. Through the globalisation of information technology, patients are able to surf the internet for viable treatment options and make their own choices with regards to their health. "Medical tourism should be seen as a choice, not a necessity," remarked Dr Prem Jagyasi, CEO of ExHealth in Dubai Healthcare City and Chairman of the Healthcare Travel Congress.

The Healthcare Travel Exhibition and Congress is open to all and will continue on the 16 and 17 November 2009 at the Al Bustan Hotel, Dubai.
Also consider reading:
Log in to request more information from IIR Middle East

Notes and media contacts

Please call +971 4 4072 743 or visit www.healthcare-travel.com for details of this.

About Healthcare Travel Exhibition & Congress:

Healthcare Travel is the only global event dedicated to the complete supply chain of the medical travel industry. Healthcare Travel Exhibition & Congress runs from 10am to 6pm from 15 to 17 November 2009 at the Al Bustan Hotel, Dubai and is open to all. It brings together the entire cluster involved in medical travel from insurers, facilitators, travel agencies, tourist boards and other non-medical services, through to hospitals, spas, medical specialists and more, who all recognise the importance of the growth of medical tourism. The event is dedicated to the development of this growing sector. www.healthcare-travel.com

About DHA:

For more information about the DHA, please visit www.dohms.gov.ae.

About Wockhardt Hospitals Group:

For more information about the Wockhardt Hospitals Group, please visit www.wockhardthospitals.net.

About Johnson & Johnson, UAE:

For more information about Johnson & Johnson, please visit www.jnj.com.

For media enquiries please contact:

Inga Stevens
PR Manager
Life Science Division
IIR Middle East
Tel: +971 4 407 2743
Tel (Office): + 971 4 336 5161 ext. 443
Fax: +971 4 336 4021

Disclaimer:

Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions